Roggeri, D. P., Zanon, E., & Roggeri, A. (2017). Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy. Farmeconomia. Health Economics and Therapeutic Pathways, 18(1). https://doi.org/10.7175/fe.v18i1.1321